
We empower exceptional teams in psychedelic medicine and consciousness expansion
Our Thesis
Humanity faces a mounting mental health crisis that cannot be properly addressed within the framework of existing treatment options. This shortage of solutions applies more broadly to an unending number of conditions affected by the central nervous system. The resurgence of interest in psychedelic therapies, combined with recent breakthroughs in precision neuromedicine and machine learning, represents an imminent, new wave of transformative mind-body optimization tools. Mystic Ventures thus makes targeted investments in early-stage companies at the intersection of biotechnology, AI, and longevity, while ultimately aiming to elevate consciousness at scale.
Portfolio Focus
Pharmaceuticals
Novel compounds and therapeutic applications
Clinical Infrastructure
Platforms enabling therapeutic delivery
Digital Therapeutics
Technology-enabled therapeutic experiences
Building the Future of Mental Healthcare
If you're a founder working on innovative solutions in psychedelic medicine or consciousness expansion, we'd love to hear from you.
Get in Touch →